We are a UK based manufacturer and supplier of branded OTC consumer health products and are looking to extend / add to our portfolio primarily by brand or company acquisition. We would also be open to discuss distribution or licensing opportunities.

My client is a major international healthcare business. They are keen to extend their existing portfolio and are seeking short and long term innovation opportunities in key OTC/Consumer health categories.

Exciting New Product launch, developed by a leading academic expert in the androgenic field. This offers a distribution opportunity which will suit a business with existing presence in sexual health or consumer self-diagnostics category.

This globally recognised consumer brand will add interest and value to the condom market with a range of top quality, premium positioned male contraceptives. Experienced European distributors required.

We are developing atorvastatin formulations that minimise or eliminate the risk of drug-drug interactions and are bioequivalent at significantly reduced dosage, resulting in a safer drug profile. For this we are leveraging OxpTarget™ , a novel drug delivery technology that provides superior controlled delivery of drugs to the distal ileum, proximal colon and colon using dual pH and bacterial trigger systems. We are using the technology to target the delivery of atorvastatin to use the colon as the portal for the entry of the drug into the systemic circulation.

OxpZero™ is a novel pharmaceutic technology that provides complete taste masking of anionic and acidic APIs. Formulation of non-tablet formats of NSAIDs, especially at high dose, is difficult due to the irritation issues typically associated with these actives. OxpZero™ allows for superior formulation of non-tablet dosage forms, for example, chewable tablets, suspensions, films and other ODTs, Importantly OxpZero™ does not alter the release profile of the API in tablet formulation. OxpZero™ has been used to develop a new Ibuprofen salt which has zero burn, zero taste and is hydrophillic for easier dispersion into suspensions.

We are offering Licener, an innovative head lice treatment for distribution worldwide. Licener is a head lice treatment that kills lice AND eggs in only one treatment of 10 min.

We are a growing pharmaceutical company with our own distribution network throughout USA. We are looking for products to buy, license or right to distribute in USA. Please contact us.

A very well established line for feminine intimate line wash The leading brand in Israel. Supplying a comprehensive solution for Feminine intimate wash needs. The line Contains 9 preparations covering women's needs in all aspects of Feminine intimate Hygiene ( 6 external vaginal washes for special needs of women , lubricating gel , soothing and application gel for external irritation , intimate wipes. Prodcuts are classified as cosmetics (lubricating is MD) Available in PL as well , and bulks

We are offering an innovative nail fungus treatment for distribution worldwide.

We are offering a fully prepared CTD dossier for submission as Well-established Use (WEU) or Traditional Herbal Medicinal Product (THMP / THR) in any EU member state. In some countries granted marketing authorisations / registrations are available. Indication: A traditional herbal medicinal product used for the relief of mild cardiac injuries (senile heart), based on traditional use only.

We are offering a fully prepared CTD dossier for submission as Well-established Use (WEU) or Traditional Herbal Medicinal Product (THMP / THR) in any EU member state. In some countries granted marketing authorisations / registrations are available. Indication: Traditional herbal medicinal product for the relief of slightly low mood and mild anxiety, sleep disturbances due to symptoms of mild anxiety, exclusively based upon long-standing use.

We are offering a fully prepared CTD dossier for submission as Well-established Use (WEU) or Traditional Herbal Medicinal Product (THMP / THR) in any EU member state. In some countries granted marketing authorisations / registrations are available. Indication (THMP): Traditional herbal medicinal product for the relief of symptoms of upper respiratory tract infections including common cold, such as sore throat, cough and blocked or runny nose.

We are offering a fully prepared CTD dossier for submission as Well-established Use (WEU) or Traditional Herbal Medicinal Product (THMP / THR) in any EU member state. In some countries granted marketing authorisations / registrations are available. Well-established Use indication: Herbal medicinal product for the treatment of mild to moderate depressive episodes (according to ICD-10). Traditional Use indication: Traditional herbal medicinal product used to relieve the symptoms of slightly low mood and mild anxiety.

We are offering a fully prepared CTD dossier for submission as Well-established Use (WEU) or Traditional Herbal Medicinal Product (THMP / THR) in any EU member state. In some countries granted marketing authorisations / registrations are available. THMP indication in UK: ''Traditional herbal medicinal product used for the prevention of migraine headaches, based on traditional use only''.

Simethicone 40 mg/0.6 ml oral drops. SIMICOL is the market leader in Israel since many years. SIMICOL is available in 30 ml bottles and is supplied with a measuring syringe. CE MARK APPROVAL SIMICOL is part of the TIPTIPOT line of OTC infant medications and is available under the CTS-label or for private labelling. Rights for other markets